This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Financial Companies: Wells Fargo (WFC) and Oceanfirst Financial (OCFC)

Tipranks - Fri Jul 3, 3:34AM CDT

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Wells Fargo (WFC) and Oceanfirst Financial (OCFC).

4th of July Sale - 70% Off

Wells Fargo (WFC)

In a report released yesterday, Richard Ramsden from Goldman Sachs maintained a Buy rating on Wells Fargo, with a price target of $93.00. The company’s shares closed last Wednesday at $85.94.

According to TipRanks.com, Ramsden is a 5-star analyst with an average return of 18.0% and a 74.4% success rate. Ramsden covers the Financial sector, focusing on stocks such as Bank of America, JPMorgan Chase, and Morgan Stanley. ;'>

Currently, the analyst consensus on Wells Fargo is a Moderate Buy with an average price target of $95.42, implying a 15.2% upside from current levels. In a report issued on June 22, RBC Capital also maintained a Buy rating on the stock with a $100.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Oceanfirst Financial (OCFC)

Raymond James analyst Daniel Tamayo reiterated a Hold rating on Oceanfirst Financial today. The company’s shares closed last Wednesday at $19.62.

According to TipRanks.com, Tamayo is a 5-star analyst with an average return of 16.5% and a 68.5% success rate. Tamayo covers the Financial sector, focusing on stocks such as Enterprise Financial Services, First Mid-Illinois Bancshares, and Farmers National Banc Oh. ;'>

Oceanfirst Financial has an analyst consensus of Hold, with a price target consensus of $19.00, which is a -2.7% downside from current levels. In a report released yesterday, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $21.50 price target.

Read More on WFC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.